Correction to: Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction i
- PDF / 571,250 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 89 Downloads / 156 Views
Cardiovascular Diabetology Open Access
CORRECTION
Correction to: Combination therapy with pemafibrate (K‑877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt‑sensitive rats fed a high‑salt and high‑fat diet Masatoki Yoshida1, Kazufumi Nakamura1* , Toru Miyoshi1, Masashi Yoshida1, Megumi Kondo1, Kaoru Akazawa1, Tomonari Kimura1, Hiroaki Ohtsuka1, Yuko Ohno1,2, Daiji Miura3 and Hiroshi Ito1
Correction to: C ardiovasc Diabetol (2020) 19:149 https://doi.org/10.1186/s12933-020-01132-2
Following publication of the original article [1], the authors identified an error in Fig. 4. The correct Fig. 4 is given. The original article has been corrected.
The original article can be found online at https://doi.org/10.1186/s1293 3-020-01132-2. *Correspondence: [email protected]‑u.ac.jp 1 Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2‑5‑1 Shikata‑cho, Kita‑ku, Okayama 700‑8558, Japan Full list of author information is available at the end of the article © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativeco mmons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/ zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Yoshida et al. Cardiovasc Diabetol
(2020) 19:213
Page 2 of 2
Relaxa on rate (%)
0
25
ND-vehicle
50
HD-vehicle HD-pitavasta n
75
NS NS
HD-pemafibrate HD-combina on
*
NS
100 1
#
10
100
1000
10000
Acetylcholine (nmol/L) Fig. 4 Effects of pitavastatin, pemafibrate or combination of pitavastatin and pemafibrate on endothelium-dependent vascular relaxations in response to acetylcholine. Rats were fed a normal diet (ND) or a high-salt and high-fat diet (HD). The rats were divided into five groups and treated with a vehicle, pitavastatin, pemafibrate (K-877), or combination of pitavastatin and pemafibrate. Data are expressed as the mean ± SD. *P
Data Loading...
